Leibniz-Institut für Molekulare Pharmakologie

Short name: 

The Leibniz-Institut für Molekulare Pharmakologie (FMP) in Berlin-Buch is a national research institution funded in equal parts by the federal government and the state of Berlin. It hosts approximately 30 PIs (annual budget: 16 m€, including third-party funding). According to a recent external evaluation, the FMP is a unique European research facility, providing state of the art technologies in the fields of molecular pharmacology and chemical biology. The research is focussed on the biological function of cell communication, membrane protein functions (e.g. ion channels, GPCRs) and the role of protein-protein interactions in signalling. Furthermore, the FMP provides expertise
in NMR-supported structural biology, chemical synthesis, rational drug design, and assay development for high-throughput screening. Through its implementation of leading HTS technologies (e.g. automated microscopes, AlphaScreen, capillary electrophoresis, impedance-measurements, genome-wide RNAi) and a unique compound library of 40,000 compounds, the FMP helps to close the gap between drug-related research in the public
and private sector. Moreover, the FMP offers the central open access screening platform of the German initiative for Chemical Biology (ChemBioNet) and manages the shared screening collection of the network. The high level of expertise provided at the FMP has been validated in several external evaluations.